New CDC data on falling rates of precancerous cervical lesions in the U.S. underscore the benefits of HPV vaccination.
A new CDC report finds that rates of precancerous lesions detected in women ages 20 to 24 have decreased by nearly 80%, lesions that would likely develop into cervical cancer years later.
A CDC report shows a dramatic drop in precancerous HPV lesions in young women. Here’s why the HPV vaccine is beneficial.
From 2008 to 2022, the incidence of cervical precancers fell by 80% among screened women aged 20 to 24 years, supporting recommendations for HPV vaccination at ages 11 to 12 years, researchers wrote in Morbidity and Mortality Weekly Report.
A new government report says that rates for precancerous lesions decreased about 80% among younger women who were screened for cervical cancer.
HPV vaccination efforts have significantly reduced the rates of precancerous cervical lesions among women, particularly those aged 20-24, showing an 80% decrease. Continued screening and prevention are essential,
Because almost all cases of cervical cancer can be traced to HPV, some countries think the vaccine will help them eliminate the disease within years.
Breast and colon cancer screening numbers have since rebounded and have even surpassed pre-pandemic screening estimates, a new American Cancer Society study has found.
A recent CDC report further demonstrates the effectiveness of the HPV vaccine against cervical cancer. HPV is a sexually transmitted infection that affects both females and males and is linked to higher risks of various forms of cancer.
Fewer precancerous lesions are being found in young women undergoing cervical cancer screenings thanks to the human papillomavirus (HPV) vaccine.   Rates of precancerous lesions in women between
Cervical cancer incidence is rising, with rural and minoritized populations experiencing worse outcomes due to suboptimal care and screening disparities. Data from 2001-2019 reveal a widening gap in cervical cancer rates between rural and urban women,
SrdjanPav/Getty Images A recent CDC report builds on existing evidence showing the effectiveness of the HPV vaccine for preventing cervical cancer. While HPV is commonly associated with females ...